Strategic Growth AI (SGAI) is an operator-led commercialization firm that integrates regulatory strategy, clinical expertise, and technical execution to accelerate payer-backed growth in AI-health, medtech, and life sciences.
Every engagement is built on evidence, aligned with reimbursement pathways, and designed for capital-efficient scale across Canada and the United States.
-
​Specialized in regulated healthcare. We align clinical, regulatory, commercial, and AI execution, end to end.
-
Faster internal cycles. Integrated planning reduces hand-offs, rework, and avoidable delays.
-
Payer-, provider-, and patient-aware. Our methods incorporate stakeholder realities from day one.
-
Evidence-informed approach. We use peer-reviewed literature, financial modeling, and real-world operations data to inform, not predetermine strategy.​​
At Strategic Growth AI, we engage at the point of highest impact, whether you’re clarifying your value proposition, preparing for payer conversations, or driving toward first commercial revenue.
​
Each engagement is tailored to your stage, runway, regulatory pathway, and evidence needs. We start lean, move quickly, and scale only when results justify it.
​
If you're navigating the path from innovation to adoption, we're here to help.
Let’s explore if we’re the right fit.
Free Fit Call
-
Step 1: If we can help, continue. If not, we’ll say so and refer you.
​
Analysis → Plan → Go/No-Go
-
Step 2: Discovery & Access (scope, metrics, data, NDA)
-
Step 3: Clarity Intelligence Sprint (map terrain, validate demand, benchmark, pathways)
-
Step 4: Decision (Go: plan + kickoff; No-Go: you keep insights)​​
We blend:
-
Lean Commercialization
-
Framework Clarity AI™ Intelligence Workflow with human-in-the-loop oversight
The result: de-risked commercialization, faster GTM with measurable ROI.
Backed peer-reviewed research, financial modeling, and longitudinal healthcare system data.
Specialist Healthcare Consulting
-
Specialist healthcare consultants deliver a 7:1 ROI: For every $1 spent on specialized pharma market research, organizations gain $7 in value.
​
-
Generalist consulting in healthcare reduces efficiency: NHS research found using generalists led to a 3.5–8% drop in efficiency and a £11,900 loss per £100,000 spent.
​​
-
Expertise matters: Peer-reviewed studies show a strong, statistically significant link (t = 0.31, p < 0.000) between consultant expertise and successful project outcomes.
​​
-
Market demand is specialist-driven: Healthcare consulting is projected to be a $32.17B market (2025), growing 10.1% annually growth fueled by need for specialist, not generalist, services.
​​
References
-
“Expert Power for Consultants and Client Outcomes,” PMC, 2025.
-
“Management Consultants and NHS Efficiency, 2017–2022,” NHS England longitudinal study.
-
“Healthcare Performance Frameworks,” BMC Health Serv Res, 2020.
-
“Global Healthcare Consulting Market,” Markets and Markets, 2025.
-
“Deloitte Pharma R&D Return on Investment Study,” 2023.​​
​
PERFORMANCE DISCLAIMER
Results based on third-party studies conducted 2020-2025. Individual client outcomes may vary significantly based on organization size, complexity, implementation quality, and market conditions. ROI calculations depend on collaborative engagement and successful execution of recommended strategies.
​